Cargando…

Population pharmacokinetics and individualized lobaplatin regimen for the treatment of Chinese small cell lung cancer in the elderly

BACKGROUND: Lobaplatin (LBP) is a third-generation platinum compound. MATERIAL AND METHODS: This prospective study was performed in 7 institutions in 2014–2016. Elderly small cell lung cancer (SCLC) patients (≥65 years old) were divided into 2 groups to receive LBP regimens according to endogenous c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Ying, Wu, Lin, Liu, Xiaoqing, Zhao, Yanqiu, Liu, Chunling, Chen, Qun, Sun, Tao, Zheng, Qingshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370119/ https://www.ncbi.nlm.nih.gov/pubmed/30653145 http://dx.doi.org/10.1097/MD.0000000000014136

Ejemplares similares

Retrospective study of the efficacy and toxicity of lobaplatin‐etoposide chemotherapy in small cell lung cancer
por: Gu, Liyan, et al.
Publicado: (2019)

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.
por: Gietema, J. A., et al.
Publicado: (1995)

Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab + Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer
por: Hou, Junjie, et al.
Publicado: (2022)

The Efficacy and Toxicity of Lobaplatin-contained Chemotherapy in Extensive-stage Small-cell Lung Cancer
por: Zhou, Ning-ning, et al.
Publicado: (2018)

Lobaplatin-based regimens outperform cisplatin for metastatic breast cancer after anthracyclines and taxanes treatment
por: Wang, Zhipeng, et al.
Publicado: (2018)

Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin
por: Liang, Xuexia, et al.
Publicado: (2022)

Intrapleural combination therapy with lobaplatin and erythromycin for non‐small cell lung cancer‐mediated malignant pleural effusion
por: Xu, Lisheng, et al.
Publicado: (2018)

Lobaplatin: Multiple toxicities: case report.
Publicado: (2020)

Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial
por: Ke, Liang-Ru, et al.
Publicado: (2017)

Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
por: Zhang, Hongming, et al.
Publicado: (2016)

Lobaplatin Inhibits the Proliferation of Hepatollular Carcinoma Through P53 Apoptosis Axis
por: Wang, Ying, et al.
Publicado: (2012)

Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
por: Ma, Dongjie, et al.
Publicado: (2018)

Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
por: Ma, Dongjie, et al.
Publicado: (2021)

Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo
por: Zhou, Zijun, et al.
Publicado: (2020)

Retrospective study of the efficacy and toxicity of lobaplatin in combined chemotherapy for metastatic breast cancer
por: Wu, Yuan, et al.
Publicado: (2019)

Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer
por: Li, Fenghu, et al.
Publicado: (2019)

Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study
por: Lu, Haohao, et al.
Publicado: (2023)

Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells
por: Wu, Qiong, et al.
Publicado: (2010)

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma
por: Zheng, Yan, et al.
Publicado: (2021)

Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
por: Yu, Junhui, et al.
Publicado: (2019)

Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles
por: Zhong, Yuxin, et al.
Publicado: (2020)

A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants
por: Song, Lin, et al.
Publicado: (2017)

Lobaplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastasis from Appendiceal and Colorectal Cancer: Safety and Efficacy Profiles
por: Pei, Wei, et al.
Publicado: (2020)

Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer
por: Zhang, Hongming, et al.
Publicado: (2019)

Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder
por: Jin, Zi-bin, et al.
Publicado: (2022)

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
por: Wang, Yang, et al.
Publicado: (2022)

Anlotinib-containing regimen for advanced small-cell lung cancer: A protocol of meta-analysis
por: Yu, Guocan, et al.
Publicado: (2021)

Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients
por: Kato, Hideo, et al.
Publicado: (2021)

Pharmacokinetics of Levornidazole Tablet in Healthy Chinese Subjects and Proposed Dosing Regimen Based on Pharmacokinetic/Pharmacodynamic Analysis
por: Wu, Hailan, et al.
Publicado: (2021)

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies
por: Wu, Hai-Tao, et al.
Publicado: (2016)

Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer
por: Zhang, Chao, et al.
Publicado: (2022)

Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX
por: Cao, Hongwen, et al.
Publicado: (2019)

Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells
por: Wang, Huan, et al.
Publicado: (2021)

Lobaplatin Enhances Radioactive (125)I Seed-Induced Apoptosis and Anti-Proliferative Effect in Non-Small Cell Lung Cancer by Suppressing the AKT/mTOR Pathway
por: Rong, Jia-hui, et al.
Publicado: (2021)

Thoracic perfusion of lobaplatin combined with endostar for treating malignant pleural effusions: A meta-analysis and systematic review
por: Wang, Cheng-Qian, et al.
Publicado: (2022)

Acute pancreatitis induced by etoposide–lobaplatin combination chemotherapy used for the treatment of lung cancer: A case report and literature review
por: Cao, Cheng-Liang, et al.
Publicado: (2017)

Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer
por: Yan, Mao-Hui, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
por: Fan, Yaxin, et al.
Publicado: (2022)

A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer
por: Yan, Min, et al.
Publicado: (2022)

Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization
por: Cao, G, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sfnit67q6cjv35apvhc9a9p8n3